Cannabidiol (CBD), a non-psychoactive compound found in the cannabis sativa plant, has shown tremendous promise for broad-ranging medical benefits, and consumers are taking notice.
Marijuana Industry
Corporate Canada warms to marijuana industry
With expectations of the Canadian Marijuana Industry exploding, well-known figures from corporate Canada are moving into prominent positions within the industry.
MCIG Enters into the Cryptocurrency Market, Partnering with Render Payment
mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, enters into the cryptocurrency market, partnering with Render Payment during its Pre-ICO (Initial Coin Offering).
ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care
Further scientific validation will be icing on the cake for ChineseInvestors.com, Inc. (OTCQB: CIIX).
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scales Up in Preparation for Canada’s Impending 2018 Recreational Cannabis Legalization
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date.
InMed Pharmaceuticals pursues medical qualities of cannabis — no smoke
People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.
Marijuana Company of America, Inc. (MCOA) is “One to Watch”
The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scaling Up to Meet Impending Spike in Cannabis Demand
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was among the very first companies to obtain a cannabis production license in that country and has since been working to change the face of medical cannabis—both in Canada and globally.
Canada’s Cannabis Market Presents Big Potential for Algae Dynamics Corp. (ADYNF)
ADYNF is a development-stage company with a portfolio of intellectual property and a signed agreement with a Licensed Producer.
The Generational Growth Opportunity for Canadian Cannabis
A recent analysis by Eight Capital, a Toronto-based investment bank, targets the potential Canadian international medical cannabis market at a staggering $142 billion over the next 15 years.
SinglePoint, Inc. (SING) – An Evolutionary Success Tale
SinglePoint, Inc. (OTC: SING) has evolved from a full-service provider of mobile technology to a publicly traded holding company focused on diversifying into horizontal markets that offer multiple revenue streams for investors.
ChineseInvestors.com, Inc. (CIIX) On Target for Impressive Gains in CBD Healthcare Markets
ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States, China and Canada.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development
InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) has created a revolutionary process that is poised to impact the cannabinoid market.
Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) Subsidiary Plans to Boost Storage Capacity
Liberty Leaf Holdings Ltd.’s (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) wholly own subsidiary, North Road Ventures, has abridged its application to Health Canada, detailing its plans to double its cannabis product lines.
India Globalization Capital, Inc. (NYSE: IGC) to Launch Medical Dispensary Product for Alzheimer’s Disease
Based on compelling data, India Globalization Capital, Inc. (NYSE MKT: IGC) was recently able to announce advances in the treatment of Alzheimer’s disease with THC.